Heart Rhythm Problems. Your Genes May Be the Reason.

SCN5A encodes the alpha subunit of the sodium channel that sits in your heart muscle cells. This channel opens and closes to allow sodium ions to rush in and out, generating the electrical impulse that makes your heart contract. Without a functioning sodium channel, your heart cannot maintain a coordinated rhythm.

Variants in SCN5A are the leading genetic cause of Brugada syndrome. Roughly 20-25% of Brugada syndrome cases carry a pathogenic SCN5A variant. These variants reduce sodium channel function, slowing the electrical conduction across your heart’s surface. The result is a distinctive ECG pattern and a real risk of sudden arrhythmia, especially during fever, sleep, or under certain medications.

If you carry an SCN5A variant, your heart struggles to conduct electrical signals smoothly. You might experience palpitations, syncope (fainting), or nocturnal agonal respiration (gasping during sleep). The risk of sudden cardiac death is real, which is why carriers need proactive monitoring with implantable devices or medications that boost sodium channel function.

KCNQ1 encodes the alpha subunit of a potassium channel that fires after the sodium rush. Its job is to allow potassium to flow out of the heart cell, restoring the electrical resting state so the heart can beat again. If this repolarization fails, your heart gets stuck in an abnormal rhythm.

KCNQ1 variants are the second most common genetic cause of Brugada syndrome and are also implicated in Long QT syndrome. Approximately 10-15% of Brugada cases involve KCNQ1. Mutations reduce potassium channel function, prolonging the time it takes your heart to reset between beats. This creates a window of vulnerability where a random electrical event can trigger a fatal arrhythmia.

You may experience syncope during exercise or emotional stress. Your ECG shows a prolonged QT interval. The threat of sudden cardiac death is real, especially in young people, and even minor triggers like swimming can be dangerous.

NOS3 produces nitric oxide in the endothelium, the inner lining of blood vessels. Nitric oxide is a signaling molecule that tells blood vessels to relax and dilate. This dilation maintains healthy blood pressure, prevents clot formation, and ensures your heart muscle gets enough oxygen-rich blood even during stress or exertion.

The Glu298Asp variant in NOS3, carried by roughly 30-40% of the population, impairs nitric oxide production. Reduced nitric oxide means your blood vessels stay somewhat constricted, blood pressure runs higher, and your heart has to work harder to pump. Over time, this contributes to atherosclerosis and increases the risk of arrhythmia during moments of cardiac stress.

You may notice high blood pressure that doesn’t respond as well to single-agent therapy, reduced exercise tolerance, or a tendency toward palpitations during or after exertion. Your coronary arteries may be more prone to spasm. If you also carry an SCN5A or KCNQ1 variant, the reduced blood flow makes arrhythmia triggers more likely.

ACE converts angiotensin I into angiotensin II, a powerful vasoconstrictor that raises blood pressure and triggers cardiac hypertrophy (thickening of the heart muscle). The ACE I/D polymorphism determines how much ACE enzyme you produce. People with the D/D genotype produce more ACE and have higher baseline angiotensin II levels.

The D/D genotype is present in roughly 25% of people with European ancestry. Those with D/D show higher ACE activity, elevated blood pressure, and increased left ventricular mass. Over time, an enlarged left ventricle becomes electrically unstable and more prone to dangerous rhythms, especially if you’re stressed or exercising hard.

If you carry the D/D variant, you may experience persistent high blood pressure despite lifestyle changes, left ventricular hypertrophy visible on an echocardiogram, and an elevated risk of arrhythmia during exertion. Your heart is literally remodeling itself into a shape that makes rhythmic stability harder.

MTHFR converts methylenetetrahydrofolate into methyltetrahydrofolate, the active form of folate needed to regulate homocysteine. Homocysteine is an amino acid that, at elevated levels, damages blood vessel walls, promotes clot formation, and destabilizes cardiac tissue. Your body recycles homocysteine using a process that depends on MTHFR and methylated B vitamins.

The C677T variant in MTHFR, found in roughly 40% of people with European ancestry, reduces enzyme efficiency by 35-40%. This slowdown allows homocysteine to accumulate in your blood, damaging vessels and increasing arrhythmia risk, even if your diet is perfect. Many cardiologists never check homocysteine, so this risk goes undetected.

You may have high homocysteine levels (often >15 micromoles per liter) despite adequate B12 and folate on standard bloodwork. You could experience vascular inflammation, increased clot risk, and accelerated atherosclerosis. If you have an underlying rhythm abnormality, elevated homocysteine amplifies the risk.

COMT breaks down catecholamines: dopamine, norepinephrine, and epinephrine. These stress hormones are essential for the fight-or-flight response, but they also make your heart more electrically irritable. COMT removes them once the threat has passed. The Val158Met variant affects COMT’s speed.

Roughly 25% of people with European ancestry carry the Met/Met slow-metabolizer variant. Slow COMT function means stress hormones linger in your bloodstream longer, keeping your nervous system and heart in a heightened state of excitability. This prolonged elevation of epinephrine and norepinephrine increases the likelihood of premature beats and triggers for more serious arrhythmias.

If you’re a slow COMT metabolizer, you likely notice that stress, caffeine, or physical exertion triggers heart palpitations more easily than it does for others. Your heart feels like it’s racing or pounding even during mild stress. You may have anxiety that feels wired rather than worried. Over time, chronic catecholamine elevation can induce or worsen an underlying arrhythmia.